Development of an in vitro dissolution method using microdialysis sampling technique for implantable drug delivery systems

Journal of Pharmaceutical Sciences

Volumn 88, Issue 10, 1999, Pages 1036-1040

  Dash, Alekha K ^a   Haney, Paul W ^a   Garavalia, Marc J ^a,b  

^a CREIGHTON UNIVERSITY   (United States)

^b ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG IMPLANT; DRUG RELEASE; DRUG SOLUBILITY; DRUG TISSUE LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; INTERMETHOD COMPARISON; MICRODIALYSIS;

EID: 0032862121     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js980480g     Document Type: Article

References (18)

1. AAPS Newsletter; American Association of Pharmaceutical Scientists: Alexandria, VA, February 1994; Vol. 9, pp 1-3.
2. Dash, A. K.; Suryanarayanan, R. An Implantable Dosage Form for the Treatment of Bone Infections. Pharm. Res. 1982, 9, 993-1002.
3. Ranade, V. J. Drug Delivery Systems 4. Implants in Drug Delivery. Clin. Pharm. 1990, 30, 871-889.
4. Dash, A. K.; Cudworth, G. C., II. Therapeutic Applications of Implantable Drug Delivery Systems. J. Pharm. Tox. Methods 1898, 41, 1-12.
5. Stahle, L. Microdialysis in Pharmacokinetics. Eur. J. Drug. Metab. Pharmacok. 1993, 18, 89-96.
6. Elmquist, W. F.; Sawchuk, R. J. Application of Microdialysis in Pharmacokinetic Studies. Pharm. Res. 1997, 14, 267-288.
7. Wang, Y.; Wong, S. L.; Sawchuk, R. J. Comparison of In Vitro and In Vivo Calibration of Microdialysis Probes Using Retrodialysis. Curr. Sep. 1991, 10, 87.
8. Herrera, A. M.; Scott, D. O.; Lunte, C. E. Microdialysis Sampling for Determination of Plasma Protein Binding of Drugs. Pharm. Res. 1990, 7, 1077-1081.
9. Yang, H.; Elmquist, W. F. The Binding of Cyclosporine A to Human Plasma: An In Vitro Microdialysis Study. Pharm. Res. 1996, 13, 622-627.
10. Knaub, S. R.; Chang, M. F.; Lunte, C. E.; Topp, E. M.; Riley, C. M. Automated Analytical Systems for Drug Development Studies. Part 4. Microdialysis System to Study the Partitioning of Lomefloxacin Across an Erythrocyte Membrane In Vitro. J. Pharm. Biomed. Anal. 1995, 14, 121-129.
11. Shah, K. P.; Chang, M.; Riley, C. M. Automated analytical Systems for Drug Development Studies. II. A System for Dissolution Testing. J. Pharm. Biomed. Anal. 1994, 12, 1519-1527.
12. Shah, K. P.; Chang, M.; Riley, C. M. Automated analytical Systems for Drug Development Studies. 3. Multi Vessel Dissolution Testing System Based on Microdialysis Sampling. J. Pharm. Biomed. Anal. 1995, 13, 1235-1245.
13. Bauer, J. F.; Elord, J.; Fornnarino, J. R.; Heathcoate, D. E.; Krough, S. K.; Linton, C. L.; Norris B. J.; Quick, J. E. Determination of Temafloxacin, Sarafloxacin, and Difloxacin in Bulk Drug and Dosage Forms by High-Performance Liquid Chromatography. Pharm. Res. 1990, 7, 1177-1180.
14. The United States Pharmacopeia, XXIII rev; United States Pharmacopeial Convention, Inc.: Rockville, MD, 1995; pp 1793-1795.
15. Ross, D.; Riley, C. M. Aqueous Solubilities of some Variously Substituted Quinolone Antimicrobials. Int. J. Pharm. 1990, 63, 237-250.
16. Oppenheimer L., Capizzi, T. P., Weppelman, R. M., Meheta. H. Dertermining the lowest limit of reliable assay measurement. Anal. Chem. 1983, 55, 638-643.
17. Kalman, S. M., Clark, D. R. and Moses, L. E. Limits of detection and quantification, as applied to an assay for digoxin. Clin. Chem. 1984, 30, 515-517.
18. Ichwan, A. M. and Dash, A. K. In vitro release of valproic acid from coated particles: Comparison of various dissolution methods. Int. J. Pharm. Adv. 1995, 1, 64-72.